M
Mankind Pharma Ltd
NSE:MANKIND
Mankind Pharma Ltd
NSE:MANKIND
Price:
2 386.1499
INR
-0.5%
Market Closed
Market Cap:
984.5B
INR
Income Statement
Earnings Waterfall
Mankind Pharma Ltd
Mankind Pharma Ltd
|
Revenue
|
116.4B
INR
|
|
Cost of Revenue
|
-33.6B
INR
|
|
Gross Profit
|
82.8B
INR
|
|
Operating Expenses
|
-58.4B
INR
|
|
Operating Income
|
24.4B
INR
|
|
Other Expenses
|
-4B
INR
|
|
Net Income
|
20.4B
INR
|
Income Statement
Mankind Pharma Ltd
Mankind Pharma Ltd
Currency: INR
Millions
TTM
| Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue |
103 348
N/A
|
106 496
+3%
|
110 180
+3%
|
116 410
+6%
|
|
| Gross Profit | |||||
| Cost of Revenue |
(33 979)
|
(32 023)
|
(32 523)
|
(33 599)
|
|
| Gross Profit |
69 369
N/A
|
74 473
+7%
|
77 657
+4%
|
82 811
+7%
|
|
| Operating Income | |||||
| Operating Expenses |
(47 895)
|
(53 039)
|
(54 641)
|
(58 387)
|
|
| Selling, General & Administrative |
(33 069)
|
(23 740)
|
(24 485)
|
(25 898)
|
|
| Depreciation & Amortization |
(3 982)
|
(4 186)
|
(4 278)
|
(5 103)
|
|
| Other Operating Expenses |
(10 844)
|
(25 113)
|
(25 878)
|
(27 386)
|
|
| Operating Income |
21 474
N/A
|
21 434
0%
|
23 016
+7%
|
24 424
+6%
|
|
| Pre-Tax Income | |||||
| Interest Income Expense |
1 739
|
(237)
|
(231)
|
(2 360)
|
|
| Non-Reccuring Items |
(83)
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
94
|
0
|
0
|
0
|
|
| Total Other Income |
769
|
3 228
|
3 723
|
3 795
|
|
| Pre-Tax Income |
23 994
N/A
|
24 425
+2%
|
26 508
+9%
|
25 858
-2%
|
|
| Net Income | |||||
| Tax Provision |
(4 576)
|
(4 519)
|
(5 125)
|
(5 228)
|
|
| Income from Continuing Operations |
19 418
|
19 907
|
21 384
|
20 631
|
|
| Income to Minority Interest |
(289)
|
(281)
|
(234)
|
(216)
|
|
| Net Income (Common) |
19 129
N/A
|
19 625
+3%
|
21 150
+8%
|
20 414
-3%
|
|
| EPS (Diluted) |
47.68
N/A
|
48.91
+3%
|
52.7
+8%
|
50.68
-4%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
